Table 1.
Baseline characteristics of poststroke patients in the placebo, escitalopram, or problem-solving therapy groups
| Placebo (n=33) | Escitalopram (n=34) | Problem-Solving Therapy (n=41) | Test Results | P value | |
|---|---|---|---|---|---|
| Age, mean(SD), y | 67.5 (12.5) | 63.7 (13.9) | 66.1 (10.6) | Kruskal-Wallis (χ2 (2)=1.90) | 0.3870 |
| Male, % | 63.6 | 61.8 | 48.8 | Fisher’s exact | 0.3825 |
| Married, % | 51.5 | 55.9 | 51.2 | Fisher’s exact | 0.9128 |
| Previous history of depression, % | 0 | 8.8 | 2.4 | Fisher’s exact | 0.1942 |
| Education, mean (SD), y | 13.3 (3.2) | 13.9 (2.6) | 14.0 (3.0) | Kruskal-Wallis (χ2 (2)=0.62) | 0.7351 |
| Stroke characteristics, % | |||||
| Large-artery atherosclerosis | 30.3 | 29.4 | 29.3 | Fisher’s exact | 1.000 |
| Small-artery occlusion | 30.3 | 20.6 | 34.1 | Fisher’s exact | 0.4117 |
| Cardioembolism/Other | 30.3 | 44.1 | 29.3 | Fisher’s exact | 0.3627 |
| Left-side lesions | 45.5 | 55.9 | 34.1 | Fisher’s exact | 0.1665 |